Daan Geerke

Dr. Daan Geerke

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 October 2005 in Journal of Computational Chemistry
Verified
Journal Article
Closed access
PDF file
MCMarkus Christen
Markus Christen
PHPhilippe H. Hünenberger
Philippe H. Hünenberger
DBDirk Bakowies
Dirk Bakowies
RBRiccardo Baron
Riccardo Baron
RBRoland Bürgi
Roland Bürgi
WGWilfred F. van Gunsteren
Wilfred F. van Gunsteren

5 October 2018 in Journal of Chemical Theory and Computation
Verified
Journal Article
Closed access
MSMartin Stroet
Martin Stroet
BCBertrand Caron
Bertrand Caron
KVKoen M. Visscher
Koen M. Visscher
DGDaan Geerke
Daan Geerke
AMAlpeshkumar K. Malde
Alpeshkumar K. Malde
AMAlan Edward Mark
Alan Edward Mark

8 June 2006 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
WGWilfred F. van Gunsteren
Wilfred F. van Gunsteren
DBDirk Bakowies
Dirk Bakowies
RBRiccardo Baron
Riccardo Baron
ICIndira Chandrasekhar
Indira Chandrasekhar
MCMarkus Christen
Markus Christen
HYHaibo B. Yu
Haibo B. Yu

22 August 2011 in Journal of Chemical Theory and Computation
Verified
Journal Article
Closed access
AEAndreas P. Eichenberger
Andreas P. Eichenberger
JAJane R. Allison
Jane R. Allison
JDJožica Dolenc
Jožica Dolenc
DGDaan Geerke
Daan Geerke
BHBruno A. C. Horta
Bruno A. C. Horta
WGWilfred F. van Gunsteren
Wilfred F. van Gunsteren

23 September 2011 in Leukemia
Verified
Journal Article
Open access
PDF file
NFN E Franke
N E Franke
DND Niewerth
D Niewerth
YAY G Assaraf
Y G Assaraf
JMJ van Meerloo
J van Meerloo
KVK Vojtekova
K Vojtekova
JCJacqueline Cloos
Jacqueline Cloos
Proteasome inhibition is a novel treatment for several hematological malignancies. However, resistance to the proteasome inhibitor bortezomib (BTZ, Velcade) is an emerging clinical impediment. Mutations in the β5 subunit of the proteasome, the primary target of BTZ, have been associated with drug resistance. However, the exact mechanism by which these mutations contribute to BTZ resistance, is still largely unknown. Toward this end, we here developed BTZ-resistant multiple myeloma (8226) and acute lymphoblastic leukemia (CCRF-CEM) cell line models by exposure to stepwise increasing concentrations of BTZ. Characterization of the various BTZ-resistant cells revealed upregulation of mutant β5 subunit of the proteasome. These newly identified β5-subunit mutations, along with previously described mutations, formed a mutation cluster region in the BTZ-binding pocket of the β5 subunit, that of the S1 specificity pocket in particular. Moreover, we provide the first evidence that the mechanism underlying BTZ resistance in these tumor cells is impaired binding of BTZ to the mutant β5 subunit of the proteasome. We propose that proteasome subunit overexpression is an essential compensatory mechanism for the impaired catalytic activity of these mutant proteasomes. Our findings further suggest that second-generation proteasome inhibitors that target the α7 subunit of the proteasome can overcome this drug resistance modality.

1 March 2013 in Journal of Computational Biology
Verified
Journal Article
Closed access
SCStefan Canzar
Stefan Canzar
MEMohammed El-Kebir
Mohammed El-Kebir
RPRené Pool
René Pool
KEKhaled Elbassioni
Khaled Elbassioni
AMAlpeshkumar K. Malde
Alpeshkumar K. Malde
GKGunnar Klau
Gunnar Klau
Molecular simulation techniques are increasingly being used to study biomolecular systems at an atomic level. Such simulations rely on empirical force fields to represent the intermolecular interactions. There are many different force fields available—each based on a different set of assumptions and thus requiring different parametrization procedures. Recently, efforts have been made to fully automate the assignment of force-field parameters, including atomic partial charges, for novel molecules. In this work, we focus on a problem arising in the automated parametrization of molecules for use in combination with the gromos family of force fields: namely, the assignment of atoms to charge groups such that for every charge group the sum of the partial charges is ideally equal to its formal charge. In addition, charge groups are required to have size at most k. We show -hardness and give an exact algorithm that solves practical problem instances to provable optimality in a fraction of a second.